| Date | Title | Description | |
|---|---|---|---|
| 22 Jun 2021 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. | Download |
| 22 Jun 2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | Download |
| 29 Apr 2021 | On business and financial situation | The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States. | Download |
| 12 Apr 2021 | On business and financial situation | The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. | Download |
| 02 Mar 2021 | On business and financial situation | The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 31 May 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI releases the information related to its General Shareholders Meeting | Download |
| 26 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the 2017 Ordinary General Shareholders Meeting | Download |
| 21 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the General Shareholders Meeting | Download |
| 21 Apr 2017 | Información sobre resultados | ROVI releases the press release related to the 2017 first quarter results. | Download |
| 21 Apr 2017 | Información sobre resultados | ROVI releases the presentation related to the 2017 first quarter results | Download |